RNA sequencing service for CCG (non-severable) - POP: 08/30/2024 - 08/29/2029
Active Awarded Last action
- Contract number
- 75N91024F00001
- Awardee
-
Azenta US Inc. UEI FW1MQC5H7K56
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,722,000
Award facts
- Opportunity
-
- 2024E01 Solicitation number
- Contract value 94% obligated
-
- $1,722,000.00 Current, with exercised options
- $1,836,800.00 Potential, with all options
- Completion date 43% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46241, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,722,000 |
About this award
This is a $1,836,800 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Azenta US Inc., doing business as Brooks Life Sciences Inc. The contract is for RNA sequencing services in support of the NCI's Genomic Characterization Centers program, with a period of performance from August 30, 2024 to August 29, 2029. This award is part of the NCI Genomic Characterization Centers, an IDIQ contract vehicle that allows streamlined procurement of genomic services for the agency's research initiatives. Azenta is a provider of life sciences products and services, including sample management, genomic analysis, and laboratory equipment, with extensive experience supporting federal agencies like the NIH, VA, DoD, and USDA. This contract does not utilize any set-aside designations.
Quick answers
Who was awarded contract 75N91024F00001?
75N91024F00001 was awarded to Azenta US Inc. by National Cancer Institute (National Institutes of Health) on August 30, 2024.
How much is contract 75N91024F00001 worth?
The government has obligated $1,722,000 on 75N91024F00001. Its potential value, with all options, is $1,836,800.
Is contract 75N91024F00001 an order under another contract?
Yes. 75N91024F00001 is a delivery order under 75N91019D00030, an indefinite delivery contract, on NCI Genomic Characterization Centers.
Was contract 75N91024F00001 competed?
The extent of competition for 75N91024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award